24/7 Customer Support

Idiopathic Pulmonary Fibrosis Market – Industry Dynamics, Market Size, and Opportunity Forecast to 2030

Global Idiopathic Pulmonary Fibrosis Market By Therapy (Esbriet (Pirfenidone), Ofev (Nintedanib), Tipelukast, Pamrevlumab, KD025, PRM 151, GKT831, Others); By Region (United States, EU5 (Germany, Spain, Italy, France, United Kingdom), and Japan)- Insights, Epidemiology and Forecast– 2030

Market forecasts for Idiopathic Pulmonary Fibrosis predict the growth of over 9% from 2021 to 2030. Increasing geriatric population numbers and rising cigarette smoking populations are driving Read more... Read More

Final report will be updated to address the impact of COVID-19 on this particular market
  • Published On: 30-Jul-2021  |  Format: pdfpowerpointexcel  |  Report ID: AA0721084

Ask For Customization